GLI1 and neoplasm: Some examples are breast cancer, where high GLI1 expression measured in a TMA containing 204 tumor samples was associated with poor prognosis and progressive stages of disease (49) or bone and soft tissue sarcomas, where higher GLI1 expression correlated with more aggressive outcomes (50).